| Use of PER977 to reverse the anticoagulant effect of edoxaban JE Ansell, SH Bakhru, BE Laulicht, SS Steiner, M Grosso, K Brown, ... New England Journal of Medicine 371 (22), 2141-2142, 2014 | 518 | 2014 |
| Oral delivery of proteins by biodegradable nanoparticles SH Bakhru, S Furtado, AP Morello, E Mathiowitz Advanced drug delivery reviews 65 (6), 811-821, 2013 | 199 | 2013 |
| Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban JE Ansell, SH Bakhru, BE Laulicht, SS Steiner, MA Grosso, K Brown, ... Thrombosis and haemostasis 117 (02), 238-245, 2017 | 163 | 2017 |
| Small molecule antidote for anticoagulants B Laulicht, B Laulicht, B Laulicht, B Laulicht, S Bakhru, S Bakhru, C Lee, ... Circulation 126 (suppl_21), A11395-A11395, 2012 | 127 | 2012 |
| New developments in anticoagulants: past, present and future JI Weitz, J Harenberg Thrombosis and haemostasis 117 (07), 1283-1288, 2017 | 109 | 2017 |
| Antidote for new oral anticoagulants: mechanism of action and binding specificity of PER977 B Laulicht, S Bakhru, X Jiang, L Chen, D Pan, M Grosso, Y Morishima, ... J Thromb Haemost 11 (suppl 2), 1-84, 2013 | 95 | 2013 |
| Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin JE Ansell, BE Laulicht, SH Bakhru, M Hoffman, SS Steiner, JC Costin Thrombosis research 146, 113-118, 2016 | 93 | 2016 |
| Enhanced cellular uptake and long-term retention of chitosan-modified iron-oxide nanoparticles for MRI-based cell tracking SH Bakhru, E Altiok, C Highley, D Delubac, J Suhan, TK Hitchens, C Ho, ... International journal of nanomedicine, 4613-4623, 2012 | 68 | 2012 |
| Reversal agents in development for the new oral anticoagulants J Costin, J Ansell, B Laulicht, S Bakhru, S Steiner Postgraduate medicine 126 (7), 19-24, 2014 | 52 | 2014 |
| Spherical solid He nanometer bubbles in an anisotropic complex oxide A Ofan, L Zhang, O Gaathon, S Bakhru, H Bakhru, Y Zhu, D Welch, ... Physical Review B 82 (10), 104113, 2010 | 52 | 2010 |
| Studies on C-phycocyanin from Cyanidium caldarium, a eukaryote at the extremes of habitat LE Eisele, SH Bakhru, X Liu, R MacColl, MR Edwards Biochimica et Biophysica Acta (BBA)-Bioenergetics 1456 (2-3), 99-107, 2000 | 52 | 2000 |
| Nonclinical safety assessment of PER977: a small molecule reversal agent for new oral anticoagulants and heparins DW Sullivan Jr, SC Gad, B Laulicht, S Bakhru, S Steiner International Journal of Toxicology 34 (4), 308-317, 2015 | 51 | 2015 |
| Compositional and structural changes in LiNbO3 following deep He+ ion implantation for film exfoliation RM Roth, D Djukic, YS Lee, RM Osgood, S Bakhru, B Laulicht, K Dunn, ... Applied physics letters 89 (11), 2006 | 51 | 2006 |
| Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulants J Ansell, BE Laulicht, SH Bakhru, A Burnett, X Jiang, L Chen, C Baker, ... Blood, The Journal of the American Society of Hematology 137 (1), 115-125, 2021 | 47 | 2021 |
| Direct and cell signaling-based, geometry-induced neuronal differentiation of neural stem cells S Bakhru, AS Nain, C Highley, J Wang, P Campbell, C Amon, S Zappe Integrative biology 3 (12), 1207-1214, 2011 | 46 | 2011 |
| Electro-optically tunable second-harmonic-generation gratings in ion-exfoliated thin films of periodically poled lithium niobate D Djukic, G Cerda-Pons, RM Roth, RM Osgood, S Bakhru, H Bakhru Applied physics letters 90 (17), 2007 | 41 | 2007 |
| Polymer-Based Microstructures B Laulicht, S Bakhru US Patent App. 10/577,785, 2007 | 40 | 2007 |
| PER977: a synthetic small molecule which reverses over-dosage and bleeding by the new oral anticoagulants S Bakhru, B Laulicht, X Jiang, L Chen, D Pan, M Grosso, Y Morishima, ... Circulation 128 (suppl_22), A18809-A18809, 2013 | 39 | 2013 |
| Reversal of anticoagulant-induced bleeding in external and internal bleeding models by PER977, a small molecule anticoagulant antidote S Bakhru, B Laulicht, X Jiang, L Chen, M Grosso, Y Morishima, K Brown, ... Circulation 130 (suppl_2), A19361-A19361, 2014 | 33 | 2014 |
| Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects J Ansell, S Bakhru, BE Laulicht, G Tracey, S Villano, D Freedman European Heart Journal 43 (10), 985-992, 2022 | 32 | 2022 |
